The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Diagnostic Performance of the GenoType MTBDRplus Version 2 Line Probe Assay Is Equivalent to That of the Xpert MTB/RIF Assay
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 50, Issue 11, Pages 3712-3716
Publisher
American Society for Microbiology
Online
2012-09-13
DOI
10.1128/jcm.01958-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early tuberculosis treatment monitoring by Xpert® MTB/RIF: Figure 1–
- (2012) Paolo Miotto et al. EUROPEAN RESPIRATORY JOURNAL
- False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]
- (2012) A. Van Rie et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- First Evaluation of an Improved Assay for Molecular Genetic Detection of Tuberculosis as Well as Rifampin and Isoniazid Resistances
- (2012) V. Crudu et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting
- (2011) Grant Theron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis [Short communication]
- (2011) S. E. Smith et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Comparison of the Xpert MTB/RIF Test with an IS6110-TaqMan Real-Time PCR Assay for Direct Detection of Mycobacterium tuberculosis in Respiratory and Nonrespiratory Specimens
- (2011) S. Armand et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of Xpert MTB/RIF RUO Assay and IS6110 Real-Time PCR for Mycobacterium tuberculosis Detection in Clinical Samples
- (2011) M. B. Miller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
- (2011) D. Hillemann et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study
- (2011) Andrea Rachow et al. PLoS One
- Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay
- (2010) R. Blakemore et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
- (2010) Catharina C. Boehme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early clinical development of anti-tuberculosis drugs: Science, statistics and sterilizing activity
- (2010) Geraint R. Davies TUBERCULOSIS
- Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis
- (2009) Adithya Cattamanchi et al. BMC INFECTIOUS DISEASES
- Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis
- (2009) Freddie Bwanga et al. BMC INFECTIOUS DISEASES
- Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature
- (2009) Chandrashekhar T Sreeramareddy et al. BMC INFECTIOUS DISEASES
- Detection and diagnosis ofMycobacterium tuberculosis
- (2009) Faten A Al-Zamel Expert Review of Anti-Infective Therapy
- The clinical relevance of Mycobacterial pharmacogenetics
- (2009) R.M. Warren et al. TUBERCULOSIS
- Drug-susceptibility testing in TB: current status and future prospects
- (2009) Elvira Richter et al. Expert Review of Respiratory Medicine
- Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa
- (2008) Marinus Barnard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Use of Light‐Emitting Diode Fluorescence Microscopy to Detect Acid‐Fast Bacilli in Sputum
- (2008) Ben J. Marais et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started